世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の遺伝子組換えヒト血清アルブミン販売市場レポート 2023年


Global Recombinant Human Serum Albumin Sales Market Report 2023

COVID-19パンデミックにより、世界の組み換えヒト血清アルブミン市場規模は2022年に7,484万米ドルであり、予測期間2023-2029年のCAGRは7.16%で2029年には1億2,107万米ドルに再調整されると予測されている。 北米... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年7月21日 US$4,000
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

COVID-19パンデミックにより、世界の組み換えヒト血清アルブミン市場規模は2022年に7,484万米ドルであり、予測期間2023-2029年のCAGRは7.16%で2029年には1億2,107万米ドルに再調整されると予測されている。
北米の組み換えヒト血清アルブミン市場規模は2022年に4,308万米ドルであり、中国は216万米ドルであった。2022年の北米の比率は57.56%、中国の比率は2.89%で、中国のシェアは2029年に3.5%に達し、分析期間を通じて年平均成長率9.87%を牽引すると予測されている。
組換えヒト血清アルブミンの世界の主要メーカーは、アルブメディックス、メルク、ヴェントリア(インビトリア)、NCPC、オリゾゲン、ハイメディアなどである。2022年には、世界の上位5社が売上高で約90.81%のシェアを占めています。

世界の遺伝子組換えヒト血清アルブミンの範囲と市場規模
組み換えヒト血清アルブミンの世界市場は、企業別、地域(国)別、タイプ別、用途別に区分される。組換えヒト血清アルブミンの世界市場におけるプレイヤー、利害関係者、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、用途別の売上高、収益、2018-2029年の予測に焦点を当てています。

企業別
アルブメディックス
メルク
ヴェントリア(インビトリア)
NCPC
オリゾゲン
ハイメディア

タイプ別セグメント
OsrHSA
ScrHSA

用途別セグメント
細胞培養培地
医療用サプリメント
その他

地域別
北米
欧州
ロシア
中国
日本
東南アジア
インド
その他の地域

ページTOPに戻る


目次

1 Recombinant Human Serum Albumin Market Overview 1
1.1 Recombinant Human Serum Albumin Product Scope 1
1.2 Recombinant Human Serum Albumin by Type 1
1.2.1 Global Recombinant Human Serum Albumin Sales by Type (2018 & 2022 & 2029) 2
1.2.2 OsrHSA 4
1.2.3 ScrHSA 5
1.3 Recombinant Human Serum Albumin by Application 5
1.3.1 Global Recombinant Human Serum Albumin Sales Comparison by Application (2018 & 2022 & 2029) 6
1.3.2 Cell Culture Media 7
1.3.3 Medical Supplements 8
1.4 Global Recombinant Human Serum Albumin Market Estimates and Forecasts (2018-2029) 9
1.4.1 Global Recombinant Human Serum Albumin Market Size in Value Growth Rate (2018-2029) 9
1.4.2 Global Recombinant Human Serum Albumin Market Size in Volume Growth Rate (2018-2029) 10
1.4.3 Global Recombinant Human Serum Albumin Price Trends (2018-2029) 11
1.5 Assumptions and Limitations 12
2 Recombinant Human Serum Albumin Estimates and Forecasts by Region 14
2.1 Global Recombinant Human Serum Albumin Market Size by Region: 2018 VS 2022 VS 2029 14
2.2 Global Recombinant Human Serum Albumin Retrospective Market Scenario by Region (2018-2023) 16
2.2.1 Global Recombinant Human Serum Albumin Sales Market Share by Region (2018-2023) 16
2.2.2 Global Recombinant Human Serum Albumin Revenue Market Share by Region (2018-2023) 17
2.3 Global Recombinant Human Serum Albumin Market Estimates and Forecasts by Region (2024-2029) 18
2.3.1 Global Recombinant Human Serum Albumin Sales Estimates and Forecasts by Region (2024-2029) 18
2.3.2 Global Recombinant Human Serum Albumin Revenue Forecast by Region (2024-2029) 19
2.4 Geographic Market Analysis: Market Facts & Figures 20
2.4.1 North America Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 20
2.4.2 Europe Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 21
2.4.3 China Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 22
2.4.4 Japan Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 23
2.4.5 Southeast Asia Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 24
2.4.6 India Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 25
2.4.7 Russia Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 26
3 Recombinant Human Serum Albumin Competition Landscape by Players 28
3.1 Global Recombinant Human Serum Albumin Sales by Players (2018-2023) 28
3.2 Global Top Recombinant Human Serum Albumin Players by Revenue (2018-2023) 29
3.3 Global Recombinant Human Serum Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Serum Albumin as of 2022) 30
3.4 Global Recombinant Human Serum Albumin Average Price by Company (2018-2023) 31
3.5 Global Key Manufacturers of Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters 31
3.6 Global Key Manufacturers of Recombinant Human Serum Albumin, Product Type 32
3.7 Global Key Manufacturers of Recombinant Human Serum Albumin, Founded Date 32
3.8 Manufacturers Mergers & Acquisitions, Expansion Plans 33
4 Recombinant Human Serum Albumin Market Size by Type 34
4.1 Global Recombinant Human Serum Albumin Historic Market Review by Type (2018-2023) 34
4.1.1 Global Recombinant Human Serum Albumin Sales by Type (2018-2023) 34
4.1.2 Global Recombinant Human Serum Albumin Revenue by Type (2018-2023) 34
4.1.3 Global Recombinant Human Serum Albumin Price by Type (2018-2023) 35
4.2 Global Recombinant Human Serum Albumin Market Estimates and Forecasts by Type (2024-2029) 35
4.2.1 Global Recombinant Human Serum Albumin Sales Forecast by Type (2024-2029) 35
4.2.2 Global Recombinant Human Serum Albumin Revenue Forecast by Type (2024-2029) 36
4.2.3 Global Recombinant Human Serum Albumin Price Forecast by Type (2024-2029) 37
5 Global Recombinant Human Serum Albumin Market Size by Application 38
5.1 Global Recombinant Human Serum Albumin Historic Market Review by Application (2018-2023) 38
5.1.1 Global Recombinant Human Serum Albumin Sales by Application (2018-2023) 38
5.1.2 Global Recombinant Human Serum Albumin Revenue by Application (2018-2023) 38
5.1.3 Global Recombinant Human Serum Albumin Price by Application (2018-2023) 39
5.2 Global Recombinant Human Serum Albumin Market Estimates and Forecasts by Application (2024-2029) 40
5.2.1 Global Recombinant Human Serum Albumin Sales Forecast by Application (2024-2029) 40
5.2.2 Global Recombinant Human Serum Albumin Revenue Forecast by Application (2024-2029) 41
5.2.3 Global Recombinant Human Serum Albumin Price Forecast by Application (2024-2029) 42
6 North America Recombinant Human Serum Albumin Market Facts & Figures 43
6.1 North America Recombinant Human Serum Albumin Sales by Company 43
6.1.1 North America Recombinant Human Serum Albumin Sales by Company (2019-2023) 43
6.1.2 North America Recombinant Human Serum Albumin Revenue by Company (2019-2023) 44
6.2 North America Recombinant Human Serum Albumin Sales Breakdown by Type 44
6.2.1 North America Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 44
6.2.2 North America Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 45
6.3 North America Recombinant Human Serum Albumin Sales Breakdown by Application 46
6.3.1 North America Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 46
6.3.2 North America Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 46
7 Europe Recombinant Human Serum Albumin Market Facts & Figures 48
7.1 Europe Recombinant Human Serum Albumin Sales by Company 48
7.1.1 Europe Recombinant Human Serum Albumin Sales by Company (2019-2023) 48
7.1.2 Europe Recombinant Human Serum Albumin Revenue by Company (2019-2023) 48
7.2 Europe Recombinant Human Serum Albumin Sales Breakdown by Type 49
7.2.1 Europe Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 49
7.2.2 Europe Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 50
7.3 Europe Recombinant Human Serum Albumin Sales Breakdown by Application 50
7.3.1 Europe Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 50
7.3.2 Europe Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 51
8 Russia Recombinant Human Serum Albumin Market Facts & Figures 52
8.1 Russia Recombinant Human Serum Albumin Sales by Company 52
8.1.1 Russia Recombinant Human Serum Albumin Sales by Company (2019-2023) 52
8.1.2 Russia Recombinant Human Serum Albumin Revenue by Company (2019-2023) 52
8.2 Russia Recombinant Human Serum Albumin Sales Breakdown by Type 53
8.2.1 Russia Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 53
8.2.2 Russia Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 54
8.3 Russia Recombinant Human Serum Albumin Sales Breakdown by Application 54
8.3.1 Russia Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 54
8.3.2 Russia Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 55
9 China Recombinant Human Serum Albumin Market Facts & Figures 56
9.1 China Recombinant Human Serum Albumin Sales by Company 56
9.1.1 China Recombinant Human Serum Albumin Sales by Company (2019-2023) 56
9.1.2 China Recombinant Human Serum Albumin Revenue by Company (2019-2023) 56
9.2 China Recombinant Human Serum Albumin Sales Breakdown by Type 57
9.2.1 China Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 57
9.2.2 China Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 58
9.3 China Recombinant Human Serum Albumin Sales Breakdown by Application 58
9.3.1 China Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 58
9.3.2 China Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 59
10 Japan Recombinant Human Serum Albumin Market Facts & Figures 60
10.1 Japan Recombinant Human Serum Albumin Sales by Company 60
10.1.1 Japan Recombinant Human Serum Albumin Sales by Company (2019-2023) 60
10.1.2 Japan Recombinant Human Serum Albumin Revenue by Company (2019-2023) 61
10.2 Japan Recombinant Human Serum Albumin Sales Breakdown by Type 61
10.2.1 Japan Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 61
10.2.2 Japan Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 62
10.3 Japan Recombinant Human Serum Albumin Sales Breakdown by Application 62
10.3.1 Japan Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 62
10.3.2 Japan Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 63
11 India Recombinant Human Serum Albumin Market Facts & Figures 64
11.1 India Recombinant Human Serum Albumin Sales by Company 64
11.1.1 India Recombinant Human Serum Albumin Sales by Company (2019-2023) 64
11.1.2 India Recombinant Human Serum Albumin Revenue by Company (2019-2023) 65
11.2 India Recombinant Human Serum Albumin Sales Breakdown by Type 65
11.2.1 India Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 65
11.2.2 India Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 66
11.3 India Recombinant Human Serum Albumin Sales Breakdown by Application 66
11.3.1 India Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 66
11.3.2 India Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 67
12 Southeast Asia Recombinant Human Serum Albumin Market Facts & Figures 68
12.1 Southeast Asia Recombinant Human Serum Albumin Sales by Company 68
12.1.1 Southeast Asia Recombinant Human Serum Albumin Sales by Company (2019-2023) 68
12.1.2 Southeast Asia Recombinant Human Serum Albumin Revenue by Company (2019-2023) 69
12.2 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Type 69
12.2.1 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 69
12.2.2 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 70
12.3 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Application 71
12.3.1 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 71
12.3.2 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 71
13 Company Profiles and Key Figures 73
13.1 Albumedix 73
13.1.1 Albumedix Corporation Information 73
13.1.2 Albumedix Recombinant Human Serum Albumin Products Offered 74
13.1.3 Albumedix Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 75
13.1.4 Albumedix Recent Developments 75
13.2 Merck 76
13.2.1 Merck Corporation Information 76
13.2.2 Merck Recombinant Human Serum Albumin Products Offered 77
13.2.3 Merck Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 77
13.2.4 Merck Recent Developments 77
13.3 Ventria (InVitria) 78
13.3.1 Ventria (InVitria) Corporation Information 78
13.3.2 Ventria (InVitria) Recombinant Human Serum Albumin Products Offered 79
13.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 80
13.3.4 Ventria (InVitria) Recent Developments 80
13.4 NCPC 81
13.4.1 NCPC Corporation Information 81
13.4.2 NCPC Recombinant Human Serum Albumin Products Offered 82
13.4.3 NCPC Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 82
13.5 Oryzogen 83
13.5.1 Oryzogen Corporation Information 83
13.5.2 Oryzogen Recombinant Human Serum Albumin Products Offered 84
13.5.3 Oryzogen Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 85
13.6 HiMedia 85
13.6.1 HiMedia Corporation Information 85
13.6.2 HiMedia Recombinant Human Serum Albumin Products Offered 86
13.6.3 HiMedia Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 86
14 Recombinant Human Serum Albumin Manufacturing Cost Analysis 87
14.1 Recombinant Human Serum Albumin Key Raw Materials Analysis 87
14.1.1 Key Raw Materials 87
14.1.2 Key Suppliers of Raw Materials 87
14.2 Proportion of Manufacturing Cost Structure 88
14.3 Manufacturing Process Analysis of Recombinant Human Serum Albumin 89
14.4 Recombinant Human Serum Albumin Industrial Chain Analysis 90
15 Marketing Channel, Distributors and Customers 91
15.1 Marketing Channel 91
15.2 Recombinant Human Serum Albumin Distributors List 91
15.3 Recombinant Human Serum Albumin Customers 94
16 Recombinant Human Serum Albumin Market Dynamics 96
16.1 Recombinant Human Serum Albumin Industry Trends 96
16.2 Recombinant Human Serum Albumin Market Drivers 96
16.3 Recombinant Human Serum Albumin Market Challenges 97
16.4 Recombinant Human Serum Albumin Market Restraints 98
17 Research Findings and Conclusion 99
18 Appendix 101
18.1 Research Methodology 101
18.1.1 Methodology/Research Approach 101
18.1.2 Data Source 104
18.2 Author Details 107
18.3 Disclaimer 109


 

ページTOPに戻る


 

Summary

Due to the COVID-19 pandemic, the global Recombinant Human Serum Albumin market size was US$ 74.84 million in 2022 and is forecast to a readjusted size of US$ 121.07 million by 2029 with a CAGR of 7.16% during the forecast period 2023-2029.
The North America Recombinant Human Serum Albumin market size was US$ 43.08 million in 2022, while China was US$ 2.16 million. The proportion of the North America was 57.56% in 2022, while Chinese percentage was 2.89%, and it is predicted that China share will reach 3.5% in 2029, trailing a CAGR of 9.87 % through the analysis period.
The global key manufacturers of Recombinant Human Serum Albumin include Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia, and etc. In 2022, the global top five players occupied for a share approximately 90.81% in terms of revenue.

Global Recombinant Human Serum Albumin Scope and Market Size
The global Recombinant Human Serum Albumin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Human Serum Albumin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2029.

By Company
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia

Segment by Type
OsrHSA
ScrHSA

Segment by Application
Cell Culture Media
Medical Supplements
Other

By Region
North America
Europe
Russia
China
Japan
Southeast Asia
India
Other Regions



ページTOPに戻る


Table of Contents

1 Recombinant Human Serum Albumin Market Overview 1
1.1 Recombinant Human Serum Albumin Product Scope 1
1.2 Recombinant Human Serum Albumin by Type 1
1.2.1 Global Recombinant Human Serum Albumin Sales by Type (2018 & 2022 & 2029) 2
1.2.2 OsrHSA 4
1.2.3 ScrHSA 5
1.3 Recombinant Human Serum Albumin by Application 5
1.3.1 Global Recombinant Human Serum Albumin Sales Comparison by Application (2018 & 2022 & 2029) 6
1.3.2 Cell Culture Media 7
1.3.3 Medical Supplements 8
1.4 Global Recombinant Human Serum Albumin Market Estimates and Forecasts (2018-2029) 9
1.4.1 Global Recombinant Human Serum Albumin Market Size in Value Growth Rate (2018-2029) 9
1.4.2 Global Recombinant Human Serum Albumin Market Size in Volume Growth Rate (2018-2029) 10
1.4.3 Global Recombinant Human Serum Albumin Price Trends (2018-2029) 11
1.5 Assumptions and Limitations 12
2 Recombinant Human Serum Albumin Estimates and Forecasts by Region 14
2.1 Global Recombinant Human Serum Albumin Market Size by Region: 2018 VS 2022 VS 2029 14
2.2 Global Recombinant Human Serum Albumin Retrospective Market Scenario by Region (2018-2023) 16
2.2.1 Global Recombinant Human Serum Albumin Sales Market Share by Region (2018-2023) 16
2.2.2 Global Recombinant Human Serum Albumin Revenue Market Share by Region (2018-2023) 17
2.3 Global Recombinant Human Serum Albumin Market Estimates and Forecasts by Region (2024-2029) 18
2.3.1 Global Recombinant Human Serum Albumin Sales Estimates and Forecasts by Region (2024-2029) 18
2.3.2 Global Recombinant Human Serum Albumin Revenue Forecast by Region (2024-2029) 19
2.4 Geographic Market Analysis: Market Facts & Figures 20
2.4.1 North America Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 20
2.4.2 Europe Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 21
2.4.3 China Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 22
2.4.4 Japan Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 23
2.4.5 Southeast Asia Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 24
2.4.6 India Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 25
2.4.7 Russia Recombinant Human Serum Albumin Estimates and Projections (2018-2029) 26
3 Recombinant Human Serum Albumin Competition Landscape by Players 28
3.1 Global Recombinant Human Serum Albumin Sales by Players (2018-2023) 28
3.2 Global Top Recombinant Human Serum Albumin Players by Revenue (2018-2023) 29
3.3 Global Recombinant Human Serum Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Serum Albumin as of 2022) 30
3.4 Global Recombinant Human Serum Albumin Average Price by Company (2018-2023) 31
3.5 Global Key Manufacturers of Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters 31
3.6 Global Key Manufacturers of Recombinant Human Serum Albumin, Product Type 32
3.7 Global Key Manufacturers of Recombinant Human Serum Albumin, Founded Date 32
3.8 Manufacturers Mergers & Acquisitions, Expansion Plans 33
4 Recombinant Human Serum Albumin Market Size by Type 34
4.1 Global Recombinant Human Serum Albumin Historic Market Review by Type (2018-2023) 34
4.1.1 Global Recombinant Human Serum Albumin Sales by Type (2018-2023) 34
4.1.2 Global Recombinant Human Serum Albumin Revenue by Type (2018-2023) 34
4.1.3 Global Recombinant Human Serum Albumin Price by Type (2018-2023) 35
4.2 Global Recombinant Human Serum Albumin Market Estimates and Forecasts by Type (2024-2029) 35
4.2.1 Global Recombinant Human Serum Albumin Sales Forecast by Type (2024-2029) 35
4.2.2 Global Recombinant Human Serum Albumin Revenue Forecast by Type (2024-2029) 36
4.2.3 Global Recombinant Human Serum Albumin Price Forecast by Type (2024-2029) 37
5 Global Recombinant Human Serum Albumin Market Size by Application 38
5.1 Global Recombinant Human Serum Albumin Historic Market Review by Application (2018-2023) 38
5.1.1 Global Recombinant Human Serum Albumin Sales by Application (2018-2023) 38
5.1.2 Global Recombinant Human Serum Albumin Revenue by Application (2018-2023) 38
5.1.3 Global Recombinant Human Serum Albumin Price by Application (2018-2023) 39
5.2 Global Recombinant Human Serum Albumin Market Estimates and Forecasts by Application (2024-2029) 40
5.2.1 Global Recombinant Human Serum Albumin Sales Forecast by Application (2024-2029) 40
5.2.2 Global Recombinant Human Serum Albumin Revenue Forecast by Application (2024-2029) 41
5.2.3 Global Recombinant Human Serum Albumin Price Forecast by Application (2024-2029) 42
6 North America Recombinant Human Serum Albumin Market Facts & Figures 43
6.1 North America Recombinant Human Serum Albumin Sales by Company 43
6.1.1 North America Recombinant Human Serum Albumin Sales by Company (2019-2023) 43
6.1.2 North America Recombinant Human Serum Albumin Revenue by Company (2019-2023) 44
6.2 North America Recombinant Human Serum Albumin Sales Breakdown by Type 44
6.2.1 North America Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 44
6.2.2 North America Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 45
6.3 North America Recombinant Human Serum Albumin Sales Breakdown by Application 46
6.3.1 North America Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 46
6.3.2 North America Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 46
7 Europe Recombinant Human Serum Albumin Market Facts & Figures 48
7.1 Europe Recombinant Human Serum Albumin Sales by Company 48
7.1.1 Europe Recombinant Human Serum Albumin Sales by Company (2019-2023) 48
7.1.2 Europe Recombinant Human Serum Albumin Revenue by Company (2019-2023) 48
7.2 Europe Recombinant Human Serum Albumin Sales Breakdown by Type 49
7.2.1 Europe Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 49
7.2.2 Europe Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 50
7.3 Europe Recombinant Human Serum Albumin Sales Breakdown by Application 50
7.3.1 Europe Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 50
7.3.2 Europe Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 51
8 Russia Recombinant Human Serum Albumin Market Facts & Figures 52
8.1 Russia Recombinant Human Serum Albumin Sales by Company 52
8.1.1 Russia Recombinant Human Serum Albumin Sales by Company (2019-2023) 52
8.1.2 Russia Recombinant Human Serum Albumin Revenue by Company (2019-2023) 52
8.2 Russia Recombinant Human Serum Albumin Sales Breakdown by Type 53
8.2.1 Russia Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 53
8.2.2 Russia Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 54
8.3 Russia Recombinant Human Serum Albumin Sales Breakdown by Application 54
8.3.1 Russia Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 54
8.3.2 Russia Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 55
9 China Recombinant Human Serum Albumin Market Facts & Figures 56
9.1 China Recombinant Human Serum Albumin Sales by Company 56
9.1.1 China Recombinant Human Serum Albumin Sales by Company (2019-2023) 56
9.1.2 China Recombinant Human Serum Albumin Revenue by Company (2019-2023) 56
9.2 China Recombinant Human Serum Albumin Sales Breakdown by Type 57
9.2.1 China Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 57
9.2.2 China Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 58
9.3 China Recombinant Human Serum Albumin Sales Breakdown by Application 58
9.3.1 China Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 58
9.3.2 China Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 59
10 Japan Recombinant Human Serum Albumin Market Facts & Figures 60
10.1 Japan Recombinant Human Serum Albumin Sales by Company 60
10.1.1 Japan Recombinant Human Serum Albumin Sales by Company (2019-2023) 60
10.1.2 Japan Recombinant Human Serum Albumin Revenue by Company (2019-2023) 61
10.2 Japan Recombinant Human Serum Albumin Sales Breakdown by Type 61
10.2.1 Japan Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 61
10.2.2 Japan Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 62
10.3 Japan Recombinant Human Serum Albumin Sales Breakdown by Application 62
10.3.1 Japan Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 62
10.3.2 Japan Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 63
11 India Recombinant Human Serum Albumin Market Facts & Figures 64
11.1 India Recombinant Human Serum Albumin Sales by Company 64
11.1.1 India Recombinant Human Serum Albumin Sales by Company (2019-2023) 64
11.1.2 India Recombinant Human Serum Albumin Revenue by Company (2019-2023) 65
11.2 India Recombinant Human Serum Albumin Sales Breakdown by Type 65
11.2.1 India Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 65
11.2.2 India Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 66
11.3 India Recombinant Human Serum Albumin Sales Breakdown by Application 66
11.3.1 India Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 66
11.3.2 India Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 67
12 Southeast Asia Recombinant Human Serum Albumin Market Facts & Figures 68
12.1 Southeast Asia Recombinant Human Serum Albumin Sales by Company 68
12.1.1 Southeast Asia Recombinant Human Serum Albumin Sales by Company (2019-2023) 68
12.1.2 Southeast Asia Recombinant Human Serum Albumin Revenue by Company (2019-2023) 69
12.2 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Type 69
12.2.1 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Type (2018-2023) 69
12.2.2 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Type (2024-2029) 70
12.3 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Application 71
12.3.1 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Application (2018-2023) 71
12.3.2 Southeast Asia Recombinant Human Serum Albumin Sales Breakdown by Application (2024-2029) 71
13 Company Profiles and Key Figures 73
13.1 Albumedix 73
13.1.1 Albumedix Corporation Information 73
13.1.2 Albumedix Recombinant Human Serum Albumin Products Offered 74
13.1.3 Albumedix Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 75
13.1.4 Albumedix Recent Developments 75
13.2 Merck 76
13.2.1 Merck Corporation Information 76
13.2.2 Merck Recombinant Human Serum Albumin Products Offered 77
13.2.3 Merck Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 77
13.2.4 Merck Recent Developments 77
13.3 Ventria (InVitria) 78
13.3.1 Ventria (InVitria) Corporation Information 78
13.3.2 Ventria (InVitria) Recombinant Human Serum Albumin Products Offered 79
13.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 80
13.3.4 Ventria (InVitria) Recent Developments 80
13.4 NCPC 81
13.4.1 NCPC Corporation Information 81
13.4.2 NCPC Recombinant Human Serum Albumin Products Offered 82
13.4.3 NCPC Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 82
13.5 Oryzogen 83
13.5.1 Oryzogen Corporation Information 83
13.5.2 Oryzogen Recombinant Human Serum Albumin Products Offered 84
13.5.3 Oryzogen Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 85
13.6 HiMedia 85
13.6.1 HiMedia Corporation Information 85
13.6.2 HiMedia Recombinant Human Serum Albumin Products Offered 86
13.6.3 HiMedia Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 86
14 Recombinant Human Serum Albumin Manufacturing Cost Analysis 87
14.1 Recombinant Human Serum Albumin Key Raw Materials Analysis 87
14.1.1 Key Raw Materials 87
14.1.2 Key Suppliers of Raw Materials 87
14.2 Proportion of Manufacturing Cost Structure 88
14.3 Manufacturing Process Analysis of Recombinant Human Serum Albumin 89
14.4 Recombinant Human Serum Albumin Industrial Chain Analysis 90
15 Marketing Channel, Distributors and Customers 91
15.1 Marketing Channel 91
15.2 Recombinant Human Serum Albumin Distributors List 91
15.3 Recombinant Human Serum Albumin Customers 94
16 Recombinant Human Serum Albumin Market Dynamics 96
16.1 Recombinant Human Serum Albumin Industry Trends 96
16.2 Recombinant Human Serum Albumin Market Drivers 96
16.3 Recombinant Human Serum Albumin Market Challenges 97
16.4 Recombinant Human Serum Albumin Market Restraints 98
17 Research Findings and Conclusion 99
18 Appendix 101
18.1 Research Methodology 101
18.1.1 Methodology/Research Approach 101
18.1.2 Data Source 104
18.2 Author Details 107
18.3 Disclaimer 109


 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る